LSTA FY 2018 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$225,000

Operating Income

-$17M

Net Income

-$16M

EPS (Diluted)

$-25.03

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$45M

Total Liabilities

$7M

Stockholders' Equity

$38M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$225,000	-$372,000	+39.5%
Operating Income	-$17M	-$28M	+38.4%
Net Income	-$16M	$23M	-170.4%